Following an overnight fast the majority of glucose disposal occurs in insulin-independent tissues, the brain (-50 % ) and splanchnic organs (-25 %), while only 25 % occurs in insulin-dependent tissues, primarily muscle [1] [2] [3] [4] . Basal glucose utilization (-2 mg.kg -~.min 1) is precisely matched by glucose production by the liver [1] [2] [3] [4] . Following glucose ingestion, the balance between uptake and output is disrupted and maintenance of glucose homeostasis depends upon three processes that must occur in a co-ordinated fashion: (1) insulin secretion; (2) stimulation of glucose uptake by splanchnic (liver and gut) and peripheral (primarily muscle) tissues in response to hyperinsulinaemia plus hyperglycaemia; (3) suppression of hepatic glucoseproduction. It logically follows that abnormalities at the level of the Beta cell, muscle, and/or liver can lead to the development of glucose intolerance. The full blown syndrome of Type 2 (non-insulin-dependent) diabetes mellitus requires the simultaneous presence of two defects, insulin resistance and impaired Beta-cell function. In Type 2 diabetes the primary or inherited defect most likely represents impaired tissue (muscle and/or liver) sensitivity to insulin. Eventually, however, the Beta cell fails to maintain a sufficiently high rate of insulin secretion to compensate for the insulin resistance, and overt diabetes mellitus ensues.
Following an overnight fast the majority of glucose disposal occurs in insulin-independent tissues, the brain (-50 % ) and splanchnic organs (-25 %), while only 25 % occurs in insulin-dependent tissues, primarily muscle [1] [2] [3] [4] . Basal glucose utilization (-2 mg.kg -~.min 1) is precisely matched by glucose production by the liver [1] [2] [3] [4] . Following glucose ingestion, the balance between uptake and output is disrupted and maintenance of glucose homeostasis depends upon three processes that must occur in a co-ordinated fashion: (1) insulin secretion; (2) stimulation of glucose uptake by splanchnic (liver and gut) and peripheral (primarily muscle) tissues in response to hyperinsulinaemia plus hyperglycaemia; (3) suppression of hepatic glucoseproduction. It logically follows that abnormalities at the level of the Beta cell, muscle, and/or liver can lead to the development of glucose intolerance. The full blown syndrome of Type 2 (non-insulin-dependent) diabetes mellitus requires the simultaneous presence of two defects, insulin resistance and impaired Beta-cell function. In Type 2 diabetes the primary or inherited defect most likely represents impaired tissue (muscle and/or liver) sensitivity to insulin. Eventually, however, the Beta cell fails to maintain a sufficiently high rate of insulin secretion to compensate for the insulin resistance, and overt diabetes mellitus ensues.
Insulin secretion in Type 2 (non-insulin-dependent) diabetes
Study of Beta-cell function in Type 2 diabetes has demonstrated a consistent pattern which reveals a complex inter-
The section "For debate..." is open to contributions dealing with issues of a particularly debatable nature in diabetology. Contributions are published either standing by themselves or accompanied by invited comments. Other comments from the readership may be published as Letters to the Editor. Manuscripts intended for publication in this section of the journal are accepted at the discretion of the Edito>in-Chief and may be subject to a referee procedure. * This For debate article has been written in response to an article previously published in Diabetologia on this subject. J.E. Gerich (1991) Diabetologia 34:607-610 play between insulin secretion and insulin sensitivity. In individuals with impaired glucose tolerance (IGT) and mild diabetes, the fasting plasma insulin concentration is invariably increased and basal insulin secretion is enhanced [5] [6] [7] (Fig. 1) . As the fasting glucose increases from 4.5 to 7.8 mmol/1 (80 to 140 mg/dl) fasting plasma insulin progressively rises. When the fasting glucose exceeds 7.8 mmol/1 (140 mg/dl), insulin secretion drops off precipitously (Fig. 1) . The inability of the pancreas to maintain its high rate of insulin secretion has important pathophysiologic implications, since it is at this point (fasting glucose = 7.8 mmol/1 = 140 mg/dl) that hepatic glucose production increases in absolute terms and begins to contribute to the elevation in fasting plasma glucose [7] . In Type 2 diabetic subjects, when glucose-stimulated insulin secretion is plotted against the fasting glucose, the same inverted "U" shaped curve is observed [1] (Fig. 2) .
The pancreatic function curves displayed in Figures 1  and 2 are consistent with the natural history of IGT and Type 2 diabetes in man [1, [8] [9] [10] [11] [12] [13] and in the rhesus monkey [14, 15] (Fig. 2) . Even before the development of IGT, insulin resistance is well-established (Fig.2) . Progression from normal to IGT to Type 2 diabetes with mild fasting hyperglycaemia (6.7 to 7.8 mmol/1 = 120 to 140 mg/dl) is associated with a marked increase in both fasting and glucose-stimulated plasma insulin levels [1, 8, 9, 13] (Fig. 2) . Overt fasting hyperglycaemia ( > 7.8 mmol/1 = 140 mg/dl) results from an inability of the Beta cell to maintain its high rate of insulin secretion (Fig. 2) . A similar pattern of insulin secretion occurs during the development of diabetes in the Rhesus monkey [14, 15] . These studies [1, 9, 10, 12, [13] [14] [15] [16] conclusively document that hyperinsulinaemia precedes Type 2 diabetes and exclude the possibility that insulinopoenia initiates the process of diabetes. Studies in ethnic groups at high risk of developing Type 2 diabetes [8, 9, [16] [17] [18] [19] [20] and in first-degree relatives of Type 2 diabetic individuals [18, 21, 22 ] also document that hyperinsulinaemia predicts the development of Type 2 diabetes.
In summary, the earliest stages of Type 2 diabetes are characterized by augmented insulin secretion, which represents a compensatory response to insulin resistance. Fig.1 . Relationship between fasting plasma glucose concentration and fasting plasma insulin concentration in normal weight control subjects, in individuals with impaired glucose tolerance, and in Type 2 (non-insulin-dependent) diabetic subjects with varying degrees of fasting hyperglycaemia. As fasting plasma glucose concentration rises from baseline to 7.8 mmol/1 (140 mg/dl) there is a progressive increase in the fasting insulin concentration. Thereafter, further rises in the fasting glucose are associated with a progressive decline in fasting insulin. In diabetic subjects with fasting glucose concentrations in excess of 11.1-12.2 mmol/1 (200-220 mg/dl), fasting insulin declines to values observed in control subjects. Reproduced from reference 7 with permission
The cause of late-onset Beta-cell failure remains unknown. Beta-cell mass is only modestly reduced (by 20-40 %) [23, 24] and genetic mutations of the insulin gene are uncommon [25] . A likely explanation for the acquired defect in insulin secretion relates to the concept of "glucose toxicity", in which chronic sustained hyperglycaemia in a (genetically) predisposed Beta cell leads to impaired insulin secretion [1, 26, 27] .
We now shall shift from the pancreas to the insulin sensitive tissues, muscle and liver. However, we shall return to the Beta cell to examine the dynamic interaction between insulin action and insulin secretion [1, 7-9, 12, 15, 21, 28-30] , since it is the disruption of this finely regulated balance which leads to the development of overt diabetes mellitus.
Insulin resistance in Type 2 diabetes
Longitudinal and cross-sectional studies have conclusively documented that hyperinsulinaemia antedates the development of Type 2 diabetes [1, 8-21, 31, 32] , and studies employing the euglycaemic insulin clamp have demonstrated that progression from normal to IGT is associated with the development of severe insulin resistance [1, 8, 9, [13] [14] [15] 21] . The defect in insulin action is seen at all plasma insulin concentrations spanning the physiologic and pharmacologic range [33] [34] [35] . These observations provide convincing evidence that insulin resistance, not impaired insulin secretion, initiates the process of Type 2 diabetes in man.
Site of insulin resistance
Following the stimulation of insulin secretion, whole body glucose homeostasis is dependent upon three tightly coupled mechanisms: (1) suppression of hepatic glucose R. A. DeFronzo: Pathogenesis of Type 2 diabetes production; (2) augmentation of splanchnic (hepatic plus gastrointestinal) glucose uptake; (3) stimulation of glucose disposal by peripheral tissues, primarily muscle. The contribution of each of these processes to the insulin resistance in Type 2 diabetes will be reviewed.
Hepatic glucose production (HGP)
De Fronzo et al. have shown that the liver of healthy subjects produces glucose at -1.8-2.2 mg. kg-1. min-1 in the postabsorptive state [1, 2, 4, 33, [36] [37] [38] [39] [40] [41] . Type 2 diabetic subjects with moderate fasting hyperglycaemia demonstrate a consistent increase (-0.5 mg. kg 1. min-1) in basal HGP (Fig.3) , which is closely correlated (r = 0.847, p < 0.001) with the degree of fasting hyperglycaemia [1, 2, 4, 33, [36] [37] [38] [39] [40] [41] . When extrapolated over 24 h the liver of a 70 kg patient with mild diabetes produces an additional 50 g of glucose each day. These results indicate that in Type 2 diabetic individuals with overt fasting hyperglycaemia ( > 7.8 mmol/1 = 140 mg/dl) excessive HGP is an important determinant of fasting hyperglycaemia. Similar results have been published by others [15, 30, 34, 35, [42] [43] [44] [45] . In the postabsorptive state, plasma insulin concentration is increased 2-3 fold in diabetic individuals [1, 2, 4, 7, 33, [36] [37] [38] [39] [40] [41] (Fig. 1) . Since hyperinsulinaemia is a powerful inhibitor of HGP [1, 2, 33, 46] , it is clear that hepatic resistance to insulin is present and contributes to the excessive basal output of glucose by the liver. In response to insulin, suppression of HGP is impaired in Type 2 diabetic patients with moderate to severe fasting hyperglycaemia [33] [34] [35] but this defect is less evident in diabetic .7mmol/1 (105 to 300mg/dl). Seventy-two age-and weightmatched control subjects are indicated by the dosed circles. In the 33 diabetic subjects with fasting plasma glucose levels below 7.8 retool/1 (1.40 mg/dl) (shaded area), the mean rate of hepatic glucose production was identical to control subjects. In diabetic subjects with fasting plasma glucose concentration above 7.8 mmol/1 (140 mg/dl), there was a progressive rise in hepatic glucose production that correlated closely (r = 0.847, p < 0.001) with the fasting plasma glucose concentration. Reproduced from reference 1 with permission patients with mild fasting hyperglycaemia [1, 2, 4, [36] [37] [38] [39] [40] [41] . From the quantitative standpoint, however, impaired suppression of HGP can account for only a small percentage (5-10 %) of the defect in whole body glucose metabolism during an englycaemic insulin clamp study [1, 2, 4, [33] [34] [35] [36] [37] [38] [39] [40] [41] .
Splanchnic (hepatic) glucose uptake
Employing hepatic vein catheterization, DeFronzo et al. [4] have documented net glucose release from the splanchnic area in the postabsorptive state in both control and Type 2 diabetic subjects, reflecting glucose production by liver. In response to insulin there was a prompt suppression of splanchnic glucose output (reflecting the inhibition of HGP) and after 2 h there was a small net splanchnic uptake of glucose, which averaged -0.5 mg.kg -1-min -1 in both control and diabetic subjects. These results demonstrate that impaired splanchnic (liver plus gut) glucose uptake cannot explain the insulin resistance observed in Type 2 diabetic subjects under euglycaemic hyperinsulinaemic conditions.
Peripheral (muscle) glucose uptake
Using the insulin clamp technique with femoral vein/artery catheterization to quantitate leg glucose exchange, muscle tissue has been shown to be the primary site of 391 insulin resistance under euglycaemic conditions. In response to insulin leg glucose uptake promptly increased M0-fold in control subjects [4] . In contrast, in Type 2 diabetic subjects the onset of insulin action was markedly delayed and leg glucose uptake was decreased by 40-50 % [4] . Similar results have been reported using the forearm catheterization technique [47] [48] [49] [50] [51] [52] [53] [54] [55] . Since in man adipocytes are quite inert [56] , the primary leg and forearm tissue responsible for glucose removal must be muscle and it can be calculated that impaired muscle glucose uptake accounts for the great majority (-90 %) of the decrease in total body glucose disposal during an insulin clamp study in Type 2 diabetic subjects [1, 4] .
Glucose disposal during oral glucose tolerance test (OGTT)
The normal route of glucose entry is via the gastrointestinal tract. Employing hepatic vein catheterization with a dual isotope technique, Ferrannini et al. [57] have examined the contribution of splanchnic and peripheral tissues to glucose disposal in healthy subjects ( (Table 2 ). As originally demonstrated by Ferrannini et al. [62] , the disturbance in glucose metabolism in Type 2 diabetic patients is accounted for by two factors: (1) decreased tissue glucose uptake (44 vs 60 over 3.5 h), (2) impaired suppression of HGP (17 vs 10 over 3.5 h). Splanchnic glucose uptake was similar in diabetic and control groups. Thus, inappropriate suppression of HGP (79 over 3.5 h) accounts for approximately one-third of the defect in total body glucose homeostasis, while reduced peripheral, presumably muscle, glucose uptake (14 g over 3.5 h) accounts for the remaining two-thirds. Essentially identical results have been reported by others [44, 52, 63, 64] , including Gerich and colleagues [52] . It should be noted that the double tracer technique is associated with significant variability since it involves the subtraction of two large numbers (Ra of 3H-glucose minus Ra of ~4C-glucose) to calculate suppression of HGR Therefore, small differences in suppression of HGP between laboratories are likely to have little physiologic meaning. The inherent variability of the method, variation in patients characteristics and differences in insulin secretory response can easily explain the 10-20 % differences in suppression of HGP reported by various investigators [44, 52, [62] [63] [64] . The important message is that everyone has found that suppression of HPG is impaired in Type 2 diabetes and that this defect can account for about one-third to one-half of the disturbance in whole body glucose homeostasis. Splanchnic glucose uptake has been reported to be normal [62] , slightly decreased [44, 52, 64] , or increased [63] and does not appear to contribute significantly to the impairment in oral glucose tolerance.
Special comment is warranted concerning whole body tissue glucose disposal following glucose ingestion. In absolute terms most, but not all [62] , studies have shown it to be normal [52] or slightly increased [44, 63, 64] (Table 2) . However, the efficiency of glucose disposal, i.e. the glucose clearance, is severely reduced. Most importantly, it is not the absolute glucose disposal rate, but rather the increment in glucose disposal above baseline which determines the rise in plasma glucose above its fasting value. In every published study [44, 52, [62] [63] [64] the incremental response in whole body glucose uptake was moderately to severely reduced in Type 2 diabetes (Table 2) . Similar results have been reported for forearm muscle glucose uptake [44, 52, 63, 64] (Table 2) . Thus, all published results [44, 52, [62] [63] [64] , including those by Gerich and colleagues [52] , are totally consistent and point out the important contribution of impaired muscle glucose disposal in Type 2 diabetes. The conclusion by Gerich [65] that muscle does not play an important role in impaired oral glucose tolerance in Type 2 diabetes stems from the failure to recognize that it is the incremental increase in muscle glucose disposal that determines the rise in plasma glucose concentration above baseline.
In summary, results of OGTT indicate that both impaired suppression of hepatic glucose production and decreased tissue, muscle, glucose uptake contribute approximately equally to the glucose intolerance of Type 2 diabetes. However, none of the currently available studies [44, 52, [62] [63] [64] 66 ] allows one to define whether the defects in hepatic and peripheral (muscle) glucose metabolism are the result of insulin resistance, diminished insulin secretion, or an impairment in the mass action effect of glucose (i. e. glucose resistance) to promote its own uptake.
Fasting hyperglycaemia in Type 2 diabetes: pancreas vs muscle vs liver
Once overt fasting hyperglycaemia (>7.8mmol/l= 140 mg/dl) has developed, HGP is elevated in absolute terms and correlates closely with the severity of fasting hyperglycaemia [1, 2, 4, 30, 33, 34, [36] [37] [38] [39] [40] [41] [42] 45] . These studies do not establish whether, in the earliest stages of Type 2 diabetes, fasting hyperglycaemia results from excessive HGR decreased efficiency of tissue glucose uptake, or some combination of the two. Recently, this question has been addressed by DeFronzo et al. [7] in 77 lean Type 2 diabetic patients. In 33 diabetic patients with fasting glucose concentration 7.8 mmol/L (Fig. 3, shaded area) , HGP (1.85+0.03mg.kg-1.min -1) was virtually identical to control subjects (1.84 + 0.02 mg. kg-1. min-z). However, this "normal" basal rate of HGP was maintained at the expense of a two-fold greater fasting plasma insulin concert- 250 300 tration (20 + 2 vs 11 + 1 gU/ml, p < 0.001) (Fig. 1 ). These observations are underscored by the recent reports by Eriksson et al.
[21] and Gulli et al. [67] and indicate that hepatic insulin resistance is well-established early in the course of Type 2 diabetes. Only the report by Gerich [65] has suggested that HOP may be increased in patients with IGT or mild Type 2 diabetes. However, the number of patients in this study [65] is very small, patient characteristics are poorly described, the patient population is obese, treatment regimen is not defined, fasting plasma insulin concentration is not provided, and OGTT results are not given. Most importantly, in six of ten individuals with fasting glucose levels between 6-7 mmol/1 (108-126 mg/dl) (see Fig. 1 of ref. 65) , HGP was clearly within the normal range and the mean HGP (11.7 + 0.3 ~tmol. kg-1 min-1) was not significantly (t= 1.42; p = 0.18; calculated from the data presented in Fig. 1 from ref. 65 ) elevated compared to 19 control subjects (11.2+0.2 pmol.kg -1. min 1) with fasting glucose between 5-6 mmol/1 (90-108 mg/dl). Thus, even the data of Gerich do not support his contention [65] . Moreover, the earlier publication by Gerich et al. [68] to which he refers did not examine diabetic patients with fasting glucose levels between 6-7 mmol/1. Lastly, the obesity index of the diabetic (BMI = 27.8 + 0.6 kg/m 2) patients in the earlier Gerich's publication [68] was much greater than in the more recent article (BMI = 25.8 + 0.8 kg/m2), and it is obvious that the patient populations in these two papers [65, 68] were quite different. Therefore, it is not appropriate to equate the metabolic disturbances described in the 393 earlier paper [68] with the patient population described in the more recent publication [65] . In summary neither the previous [68] nor present [65] publications justify the statement that in "individuals with fasting plasma glucose concentrations between 6 and 7 mmol/1, rates of glucose production are elevated" [65] . Rather, the data of Gerich et al. [65] demonstrate that HGP is not significantly elevated in the early stages of Type 2 diabetes. Similar results have been reported in a Type 2 diabetic primate model [14, 15] . During the postabsorptive state glucose uptake by all tissues equals HGP and, when viewed in absolute terms, is increased in Type 2 diabetes. However, since both fasting glucose and insulin concentrations are elevated, efficiency of tissue glucose uptake, i.e. glucose clearance rate, is markedly reduced early in the course of Type 2 diabetes [7] (Fig.4) . As the fasting glucose rises from 5.8 to 7.8 mmol/1 (105 to 140 mg/dl), glucose clearance declines linearly (r = 0.700, p < 0.001) whereas HGP remains constant (Fig. 3) . However, with fasting glucose levels above 7.8 mmol/1 (140 mg/dl), the restraining effect of hyperinsulinaemia on the liver is lost and HGP increases progressively (r = 0.847, p < 0.001) (Fig. 3) , while the decline in whole body glucose clearance plateaus at glucose levels between 7.8-10 mmol/1 (140-180 mg/dl) (Fig. 4) .
Why is fasting hyperinsulinaemia sufficient to prevent excessive HGP (Fig. 3 ), yet inadequate to maintain a normal basal rate of tissue glucose clearance (Fig. 4) in diabetics with fasting glucose < 7.8 mmol/L. This paradox is explained by the distinctive dose-response relationships between plasma insulin concentration vs hepatic glucose production and tissue glucose disposal [29, [33] [34] [35] . Small increments in plasma insulin (8 to 27 gU/ml) in normal subjects, suppress HGP by 68 %, but have no stimulatory effect on whole body glucose uptake [33] . Thus, in Type 2 diabetic subjects fasting hyperinsulinaemia is sufficient to offset the hepatic insulin resistance but does not stimulate tissue glucose uptake [29, 33, 69, 70] , resulting in a decline in basal glucose clearance (Fig. 4) .
In Type 2 diabetic subjects DeFronzo et al. [4] have shown that basal leg (muscle) glucose clearance is similar to control subjects. In contrast, Gerich et al. [68] and Firth et al. [44] have reported modestly reduced rates of glucose clearance by forearm (muscle) tissue in Type 2 diabetes in the postabsorptive state. Using hepatic vein catheterization, DeFronzo et al. have demonstrated that part of the decrease in whole body glucose clearance resides within the splanchnic tissues (liver plus gastrointestinal) [4] . However, from a purely quantitative standpoint tissues in addition to liver [4] and muscle [44, 68] must also contribute to the decline in glucose clearance. The brain represents a prime candidate to explain this decrease. In the postabsorptive state, 50-60 % of glucose disposal occurs in cerebral tissues. Brain glucose uptake is insulin-independent, saturates at plasma glucose concentrations of -2.2 mmol/1 (40 mg/dl), and remains normal in Type 2 diabetic subjects despite fasting hyperglycaemia [58] . It follows, therefore, that brain (and consequently whole body) glucose clearance must decline in Type 2 diabetic subjects with progressive increases in basal glucose concentration. It remains unknown whether tissues, in addition to muscle, splanchnic and brain, also contribute to the Fig.5 . Effect of overnight insulin infusion to normalize basal rate of hepatic glucose production in 19 normal weight Type 2 (non-insulindependent) diabetic subjects (shaded bars) and in 72 age-and weight-matched control subjects (cross-hatched bars). Despite similar rates of hepatic glucose production and a two-fold greater increase in plasma insulin concentration (p < 0.01), fasting plasma glucose remained significantly elevated in Type 2 diabetic patients vs control subjects. The decreased glucose clearance in Type 2 diabetic patients indicates a diminished efficiency of tissue glucose uptake. Reproduced from reference 7 with permission decline in basal glucose clearance in Type 2 diabetic subjects.
The defects in basal HGP and tissue glucose disposal are best appreciated by studying Type 2 diabetic subjects after overnight insulin infusion to normalize basal HGP [7] (Fig. 5 ). Despite similar rates of HGP in control and diabetic subjects and a two-fold greater plasma insulin concentration in the latter, fasting glucose remained elevated in diabetic individuals (5.8+0.2 vs 5.1+0.06 mmol/1 = 105 + 3 vs 92 + 1 mg/dl, p < 0.01). The persistent hyperglycaemia is explained by a decreased efficiency of tissue glucose removal (glucose clearance=l.71 vs 2.00 ml. kg-1. min-1, p < 0.01). Further evidence for impaired tissue glucose uptake comes from studies in which Type 2 diabetic subjects received overnight insulin infusion to normalize fasting plasma glucose concentration [7] (Fig. 6) . At identical plasma glucose concentrations, the absolute rate of tissue glucose uptake was significantly reduced in the Type 2 diabetic subjects, even though the plasma insulin concentration was more than two-fold elevated in the former group. These data unequivocally demonstrate that tissue glucose disposal is impaired in Type 2 diabetes. In contrast to the suggestion of Gerich et al. [65, 68] , these results cannot be explained simply by failure of the brain to passively enhance its uptake of glucose in response to a progressive rise in fasting plasma glucose concentration.
From currently available data it is not possible to establish which defect, i.e. hepatic insulin resistance or decreased efficiency of tissue glucose removal, develops first in the evolution of fasting hyperglycaemia in Type 2 diabetes mellitus. Three equally plausible sequences can R. A. DeFronzo: Pathogenesis of Type 2 diabetes be postulated. First, both defects develop in parallel. As hyperglycaemia ensues (due both to excessive HGP and decreased tissue glucose uptake), basal insulin secretion is stimulated (Fig. 1) . The resultant hyperinsulinaemia restores HGP to baseline, while hyperglycaemia returns tissue glucose uptake to normal. This sequence would result in normal basal rates of HGP and tissue glucose uptake but at the expense of fasting hyperglycaemia and fasting hyperinsulinaemia [1, 7] . Since the small increment in plasma insulin has no stimulatory effect on tissue glucose uptake, whole body glucose clearance falls. Second, decreased efficiency of tissue glucose uptake could represent the primary defect. As fasting plasma glucose rises, insulin secretion is enhanced; the resultant hyperglycaemia returns tissue glucose uptake to normal, while hyperinsulinaemia has two opposing actions: (1) induction of hepatic insulin resistance by down-regulating both receptor and post-receptor events [71, 72] ; (2) suppression of HGR Because these two metabolic actions of insulin offset each other, basal HGP remains unaltered. Third, hepatic insulin resistance could initiate fasting hyperglycaemia by causing a small, imperceptible rise in plasma glucose. This would stimulate insulin secretion, returning HGP to normal. ]?issue glucose uptake would remain unaltered because the small rise in plasma insulin is insufficient to augment tissue glucose uptake [29, 33, 69, 70] . Consequently, tissue glucose clearance would fall. It should be noted that the statement by Gerich [65] that "for plasma glucose to increase, glucose production must exceed glucose uptake" is not, strictly speaking, correct. For plasma glucose to increase, glucose production must transiently exceed glucose uptake or tissue glucose uptake must transiently decrease below the rate of glucose production. Studies performed under steady conditions after a metabolic perturbation has occurred and the system has Fig .6 . Effect of overnight insulin infusion to normalize the fasting plasma glucose concentration in 11 normal weight Type 2 (noninsulin-dependent) diabetic patients (shaded bars) and in 72 ageand weight-matched control subjects (cross-hatched bars). Despite identical plasma insulin concentrations the absolute rate of whole body tissue glucose uptake in the post-absorptive state was significantly reduced in the Type 2 diabetic group (p < 0.01). Reproduced from reference 7 with permission re-equilibrated cannot reconstruct the sequence of events that led to the establishment of the new steady state.
In summary, in Type 2 diabetic subjects with mild fasting hypergtycaemia ( < 7.8 mmol/1 = 140 mg/dl) both decreased efficiency of tissue glucose uptake and hepatic insulin resistance contribute to the elevated postabsorptive plasma glucose concentration.
Dynamic interaction between insulin action and insulin secretion in Type 2 diabetes
Type 2 diabetic subjects are characterized by both tissue (muscle and liver) insulin resistance and impaired insulin secretion. To fully appreciate the evolution of the fullblown diabetic condition, it is necessary to examine the dynamic interaction between insulin action and insulin secretion in the same individual over a wide range of insulin sensitivity. Three groups have provided such information [1, 8, 9, 12, 13, 28, 40, 41, 73] . In obesity (Fig, 2 ) DeFronzo, Felber and colleagues [1, 13, 41, 73] have shown that weight gain is associated with a marked reduction (40-50 % ) in insulin sensitivity. Nonetheless, glucose tolerance remains normal because the Beta cell appropriately augments its insulin secretory capacity to offset the insulin resistance. Progression from normal to IGT is associated with further reduction in insulin sensitivity. However, glucose tolerance is only mildly impaired because of a further compensatory increase in insulin secretion. Onset of overt diabetes is heralded by a modest decline in insulin secretion without any additional worsening of the insulin resistance. This modest decline in insulin secretion, in the presence of severe insulin resistance, results in frank diabetes (Fig.2) . Progression from moderate to severe diabetes is associated with a further reduction in insulin secretion without any change in insulin sensitivity (Fig. 2 ).
These observations underscore the critical interaction between insulin resistance and insulin secretion in the development of overt Type 2 diabetes. The sequence of events described above has been confirmed in Pima Indians [8, 9, 12] , lean Caucasians [13, 34] , and monkeys [14, 15] . In summary, in the earliest stage of Type 2 diabetes both hepatic and peripheral tissue resistance to insulin is well-established and is offset by the presence of compensatory hyperinsulinaemia. Overt diabetes develops only in individuals whose pancreas is unable to meet the increased and sustained demand for insulin secretion.
